Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice.

Pencille LJ, Campbell ME, Van Houten HK, Shah ND, Mullan RJ, Swiglo BA, Breslin M, Kesman RL, Tulledge-Scheitel SM, Jaeger TM, Johnson RE, Bartel GA, Wermers RA, Melton LJ 3rd, Montori VM.

Trials. 2009 Dec 10;10:113. doi: 10.1186/1745-6215-10-113.

2.

Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.

Cole RE.

Postgrad Med. 2011 Mar;123(2):131-44. doi: 10.3810/pgm.2011.03.2271. Review.

PMID:
21474901
3.

Bisphosphonates for osteoporosis in primary biliary cirrhosis.

Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009144. doi: 10.1002/14651858.CD009144.pub2. Review.

PMID:
22161446
4.
5.

Bisphosphonates for osteoporosis in people with cystic fibrosis.

Conwell LS, Chang AB.

Cochrane Database Syst Rev. 2014 Mar 14;(3):CD002010. doi: 10.1002/14651858.CD002010.pub4. Review.

PMID:
24627308
6.

Bisphosphonates for osteoporosis in people with cystic fibrosis.

Conwell LS, Chang AB.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD002010. doi: 10.1002/14651858.CD002010.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;(3):CD002010.

PMID:
22513903
7.

Fracture prevention in postmenopausal osteoporosis: a review of treatment options.

McCarus DC.

Obstet Gynecol Surv. 2006 Jan;61(1):39-50. Review.

PMID:
16359568
8.

Treatment for osteoporosis in people with ß-thalassaemia.

Bhardwaj A, Swe KM, Sinha NK, Osunkwo I.

Cochrane Database Syst Rev. 2016 Mar 10;3:CD010429. doi: 10.1002/14651858.CD010429.pub2. Review.

PMID:
26964506
9.

Bisphosphonates for steroid-induced osteoporosis.

Allen CS, Yeung JH, Vandermeer B, Homik J.

Cochrane Database Syst Rev. 2016 Oct 5;10:CD001347. Review.

PMID:
27706804
10.

Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups.

Burch J, Rice S, Yang H, Neilson A, Stirk L, Francis R, Holloway P, Selby P, Craig D.

Health Technol Assess. 2014 Feb;18(11):1-180. doi: 10.3310/hta18110. Review.

11.

Bisphosphonates for osteoporosis in people with cystic fibrosis.

Brenckmann C, Papaioannou A.

Cochrane Database Syst Rev. 2001;(4):CD002010. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD002010.

PMID:
11687132
12.

Aging bone and osteoporosis: strategies for preventing fractures in the elderly.

Ettinger MP.

Arch Intern Med. 2003 Oct 13;163(18):2237-46. Review.

PMID:
14557222
13.

Bisphosphonate therapy for osteogenesis imperfecta.

Dwan K, Phillipi CA, Steiner RD, Basel D.

Cochrane Database Syst Rev. 2016 Oct 19;10:CD005088. Review.

PMID:
27760454
14.

Medical treatment of vertebral osteoporosis.

Lippuner K.

Eur Spine J. 2003 Oct;12 Suppl 2:S132-41. Epub 2003 Sep 17. Review.

15.

Bisphosphonate therapy for osteogenesis imperfecta.

Dwan K, Phillipi CA, Steiner RD, Basel D.

Cochrane Database Syst Rev. 2014 Jul 23;(7):CD005088. doi: 10.1002/14651858.CD005088.pub3. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 19;10 :CD005088.

PMID:
25054949
16.

Risk of fracture and the concomitant use of bisphosphonates with osteoporosis-inducing medications.

Nyandege AN, Slattum PW, Harpe SE.

Ann Pharmacother. 2015 Apr;49(4):437-47. doi: 10.1177/1060028015569594. Epub 2015 Feb 9. Review.

PMID:
25667198
17.

Decision aids for people facing health treatment or screening decisions.

Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD001431. doi: 10.1002/14651858.CD001431.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD001431.

PMID:
21975733
18.

Is treatment of early postmenopausal women with bisphosphonates justified?

Epstein S.

Int J Clin Pract. 2007 Jun;61(6):963-71. Review.

PMID:
17504359
19.

Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference.

Beard MK.

Curr Med Res Opin. 2012 Jan;28(1):141-7. doi: 10.1185/03007995.2011.643296. Epub 2011 Dec 6. Review.

PMID:
22103779
20.

[Update on treatment of postmenopausal osteoporosis].

Body JJ.

Rev Med Brux. 2008 Sep;29(4):301-9. Review. French.

PMID:
18949981

Supplemental Content

Support Center